Particle.news

Download on the App Store

UK Tightens Rules for Online Prescriptions of Weight-Loss Drugs

New guidelines require stricter verification processes to address safety concerns and reduce inappropriate access to medications like Wegovy and Mounjaro.

Injection pens and boxes of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. REUTERS/Victoria Klesty/Illustration/File Photo
A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah, U.S., March 29, 2023. REUTERS/George Frey/File Photo
Image
Image

Overview

  • The General Pharmaceutical Council (GPhC) now mandates online pharmacies to independently verify patient information, such as BMI, through video consultations, in-person assessments, or medical records.
  • Weight-loss medications, including Wegovy and Mounjaro, have been classified as high-risk drugs requiring additional safeguards to prevent misuse.
  • The updated rules prohibit prescribing based solely on online questionnaires or email exchanges and require two-way consultations with prescribers.
  • Pharmacies must ensure no conflicts of interest, such as incentives for issuing prescriptions, and adhere to stricter advertising standards in collaboration with regulatory bodies.
  • Enforcement measures for non-compliance include improvement plans, restrictions on medication supply, and potential suspension of pharmacy operations.